1. Garcia MA, Casadeval Sand A. Global Warming Will Bring New Fungal Diseases for Mammals. mBIO 2010; 1: Issue 1 e00061-10
2. Casadevall A, Coelho C, Cordero RBJ, et al. The capsule of Cryptococcus neoformans. Virulence 2018; 1; 822-831.
3. Guerrero A, Jain N, Goldman DL, Fries, BC. Phenotypic switching in Cryptococcus neoformans Microbiology 2006; 152: 3–9.
4. Casadeval A. Pathogenicity and virulence of Cryptococcus neoformans from an environmental perspective. Virulence 2025; 16:2547090.
5. Sancak B, Çerikçioğlu N. Mantarların Genel Özellikleri ve Tanı Yöntemleri. Willke Topçu A, Söyletir G, Doğanay M, eds. Enfeksiyon Hastalıkları ve Mikrobiyolojisi: Sistemlere Göre Enfek-
siyonlar. 4. Baskı. Nobel Kitabevi, 2017; 2097-2106.
6. Fontaine T, Latge JP. Galactomannan produced by A.fumigatus: An update of the structure, biosynthesis and biological emblematic fungal marker. J Fungi 2020; 283.
7. Szymański M, Chmielewska S, Czyżewska U, Malinowska M, Tylicki A. Echinocandins – structure, mechanism of action and use in antifungal therapy. J Enzyme Inhib Med Chem 2022; 16:
876–894.
8. Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 2014; 27: 484–492.
9. Rezai M, Hama NH. Antibacterial, antifungal, antiviral, and anticancer activities of chitosan and its derivatives: Basic mechanism. Micro Nano Bio Aspects 2024; 3: 23-28.
10. Sant DG, TupeSG, Ramana CV, Deshpande MV. Fungal cell membrane-promising drug target for antifungal therapy. J Appl Microbiol 2016; 121: 1498-1510.
11. Miguel A, Ortiz N, Gabaldón T. Fungal evolution: cellular, genomic and metabolic complexity. Biol Rev 2020; 95: 1198–1232.
12. Walsh TH, Hayden RT, Larone DH, eds. Larone’s Medically Important Fungi. A Guide to Identification. 6th edition. ASM Press Washington D.C.; 2018.
13. Wallen RM, Perlin MH. An overview of the function and maintenance of sexual reproduction in dikaryotic fungi. Front Microbiol 2018;9: 503.
14. Riley MM S. Infection Control and Prevention Considerations for the Intensive Care Unit. Critical Care Nursing Clinics of North America 2021;33.
15. Salgado-Castillo N, López-Peña HA, Díaz R, Solis KP, Ponce-Alquicira E, Soriano-Santos J. Fungal melanins and their potential applications. BioResources 2000; 18: 8688-8706.
16. Khan R, Anwar F, Ghazali FM. A comprehensive review of mycotoxins: Toxicology, detection, and effective mitigation approaches. Heliyon e28361
17. Janik E, Niemcewicz M, Podogrocki M, Ceremuga M, Stela M, et al. T-2 Toxin—The most toxic Trichothecene Mycotoxin: Metabolism, Toxicity, and Decontamination Strategies. Molecules
2021; 26: 6868.
18. Conrado R, Gomes TC, Sales G, Roque C. A. Olivia D SO A. Overview of bioactive fungal secondary metabolites: Cytotoxic and Antimicrobial Compounds. Antibiotics 2022; 11; 1604.
19. Palwe SD, Borde Y, Sonawane HB. Endophytic fungi: a source of potential anticancer compounds. Studies in Fungi 2021; 6: 188-203.
20. Borman MA, Abdolrasouli A, Elizabeth M, Johnson EM. Name changes for fungi of medical importance, 2022–2024, Developments in fungal taxonomy. J Clin Microbiol 2025; 63: e0204124.
21. Kidd S, Abdolrasoul A, Hagen F. Fungal Nomenclature: Managing change is the name of the name. Open Forum Infect Dis 2023;10: ofac559.